Ideal Power receives Nasdaq non-compliance notice for audit committee composition after director's death

Ideal Power Inc.

Passing of director David B. Eisenhaure left Audit Committee with only two independent directors, violating Nasdaq Listing Rule 5605(c)(2)(A).
Cure period ends at earlier of next annual meeting or October 21, 2022; if before April 19, 2022, then by that date.
Board engaged a search firm to fill the vacancy and expects to be compliant within the cure period.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.